Our group's aim is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma. The goal of our laboratory is to improve the treatment and survival of ...

A ‘TripAdvisor-style’ website that helps scientists choose the best small-molecule tools for their experiments has been greatly expanded to include expert reviews of hundreds of chemical probes that ...

Dr Caroline Furness is a Group Leader at the Institute of Cancer Research and a Consultant Paediatric/TYA Haematologist at the Royal Marsden Hospital. She specialises in the care of paediatric ...

Dr Furness completed her medical training at Cambridge and Oxford University and her PhD at the Institute of Cancer Research. She trained in clinical haematology at the Royal Marsden Hospital and ...

Scientists have developed a machine learning tool that can predict how an aggressive type of breast cancer will respond to treatment, and when it will return. Invasive lobular carcinoma (ILC) – which ...

One year of treatment with the targeted drug olaparib improves long-term survival in women with high-risk, early-stage breast cancer with mutations in BRCA1 or BRCA2 genes, new results from a major ...

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and ...

Camilla Keeling was a month away from celebrating her 61st birthday when she was diagnosed with skin cancer. After having it removed, she thought she was in the clear but not long after, she found out ...

Dr Radzisheuskaya’s group investigates how post-translational modifications on histone proteins regulate genome organization and stability and how they contribute to the development of cancer. Alex is ...

Image: (from left to right) Sally Clarke, Andrew Castle, Anthony Horowitz, Marjorie Coles and Adam Kay. Credit: Adam Duke Photography Christmas arrived in style as celebrities and guests got into the ...